News & Updates

Use of an SGLT2i in a patient with cardiovascular-kidney-metabolic syndrome

20 Feb 2025 by

A 70-year-old Chinese male patient had an acute myocardial infarction (MI) at the age of 60 years and underwent a successful percutaneous coronary intervention. At the time of presentation in 2013, he had cardiovascular-kidney-metabolic (CKM) syndrome, including obesity with a body mass index (BMI) of 28 kg/m², type 2 diabetes mellitus (T2DM) with HbA_1c of 7.5 percent, chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) of 50 mL/min/1.73 m²and urine albumin-to-creatinine ratio (UACR) of 4 mg/mmol, and heart failure with reduced ejection fraction (HFrEF) and left ventricular ejection fraction (LVEF) of 40 percent.

Use of an SGLT2i in a patient with cardiovascular-kidney-metabolic syndrome

20 Feb 2025

Pesticide exposure carries increased risk of T2D

19 Feb 2025

Individuals exposed to organochlorine- or pyrethroid-based pesticides may be at heightened risk of type 2 diabetes (T2D), as suggested in a study.

Pesticide exposure carries increased risk of T2D

19 Feb 2025

SGLT-2is, GLP-1RAs cut risk of COPD flare-ups

19 Feb 2025 by

In adults with type 2 diabetes and active chronic obstructive pulmonary disease (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) may also reduce the risk of COPD exacerbations, according to a study.

SGLT-2is, GLP-1RAs cut risk of COPD flare-ups

19 Feb 2025

Increasing obesity trajectory in midlife tied to cognitive decline, dementia

18 Feb 2025 by

Individuals with a persistently high or an increasing pattern of general and central obesity trajectories throughout middle and late life appear to be at greater risk of cognitive decline and developing dementia, a study has shown.

Increasing obesity trajectory in midlife tied to cognitive decline, dementia

18 Feb 2025

Obesity, overweight in adolescence tied to risk of serious morbidity in early adulthood

17 Feb 2025

Overweight or obesity during adolescence appears to come with an increased risk of developing serious morbidity before age 25, according to a retrospective study.

Obesity, overweight in adolescence tied to risk of serious morbidity in early adulthood

17 Feb 2025

Community partnerships boost success of youth obesity treatment

17 Feb 2025 by

Strategic partnerships between healthcare systems and community organizations, such as public parks and recreation (P&R) centres, represent a promising strategy for tackling youth obesity, helping increase access to health behaviour and lifestyle interventions and improve weight outcomes.

Community partnerships boost success of youth obesity treatment

17 Feb 2025

Social media use tied to binge eating in early adolescence

17 Feb 2025

Social media addiction (SMA) appears to exert some influence on binge eating habits in early adolescence, suggests a recent study, noting a difference in the association by sex and weight status.

Social media use tied to binge eating in early adolescence

17 Feb 2025

Calorie labelling results in small reductions in calories purchased

17 Feb 2025

Calorie labelling on fast-food purchases produces slight decreases in calories obtained across all population subgroups, but not for rural census tracts, according to a US study. Some subgroups have also derived more benefits from this practice.

Calorie labelling results in small reductions in calories purchased

17 Feb 2025

T2D drug may assist in stroke prevention after minor stroke, high-risk TIA

15 Feb 2025 by

Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide in Chinese patients with type 2 diabetes (T2D) has the potential to reduce the risk of stroke recurrence and improve prognosis after a minor acute ischaemic stroke or a high-risk transient ischaemic attack (TIA), as suggested in the randomized, open-label LAMP study.

T2D drug may assist in stroke prevention after minor stroke, high-risk TIA

15 Feb 2025

No clear link between SGLT-2 inhibitors and dementia

15 Feb 2025

There appears to be no conclusive evidence to suggest that the use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors may help reduce the risk of dementia, as shown in a population-based retrospective cohort study.

No clear link between SGLT-2 inhibitors and dementia

15 Feb 2025

News & Updates

Filter by Specialty:

Specialty:

Use of an SGLT2i in a patient with cardiovascular-kidney-metabolic syndrome

Use of an SGLT2i in a patient with cardiovascular-kidney-metabolic syndrome

Pesticide exposure carries increased risk of T2D

Pesticide exposure carries increased risk of T2D

SGLT-2is, GLP-1RAs cut risk of COPD flare-ups

SGLT-2is, GLP-1RAs cut risk of COPD flare-ups

Increasing obesity trajectory in midlife tied to cognitive decline, dementia

Increasing obesity trajectory in midlife tied to cognitive decline, dementia

Obesity, overweight in adolescence tied to risk of serious morbidity in early adulthood

Obesity, overweight in adolescence tied to risk of serious morbidity in early adulthood

Community partnerships boost success of youth obesity treatment

Community partnerships boost success of youth obesity treatment

Social media use tied to binge eating in early adolescence

Social media use tied to binge eating in early adolescence

Calorie labelling results in small reductions in calories purchased

Calorie labelling results in small reductions in calories purchased

T2D drug may assist in stroke prevention after minor stroke, high-risk TIA

T2D drug may assist in stroke prevention after minor stroke, high-risk TIA

No clear link between SGLT-2 inhibitors and dementia

No clear link between SGLT-2 inhibitors and dementia